Effectiveness and Safety of Iguratimod in Treating Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis

Objectives: We aimed to assess the effectiveness and safety of iguratimod (IGU) in treating primary Sjögren’s syndrome (pSS) by meta-analysis. Methods: Eight databases and two clinical trial websites were searched from conception to August 10, 2020, for relevant randomized controlled trials (RCTs) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Jincheng, Wang, Xuan, Riaz, Farooq, Zhang, Tongyangzi, Gao, Ronglin, Pan, Shengnan, Wu, Zhenzhen, Liang, Yuanyuan, Zhuang, Shuqi, Tang, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017188/
https://www.ncbi.nlm.nih.gov/pubmed/33815105
http://dx.doi.org/10.3389/fphar.2021.621208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017188/
https://www.ncbi.nlm.nih.gov/pubmed/33815105
http://dx.doi.org/10.3389/fphar.2021.621208

Ejemplares similares